JP2025508359A5 - - Google Patents
Info
- Publication number
- JP2025508359A5 JP2025508359A5 JP2024546431A JP2024546431A JP2025508359A5 JP 2025508359 A5 JP2025508359 A5 JP 2025508359A5 JP 2024546431 A JP2024546431 A JP 2024546431A JP 2024546431 A JP2024546431 A JP 2024546431A JP 2025508359 A5 JP2025508359 A5 JP 2025508359A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- subject
- count
- composition according
- administration period
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263310751P | 2022-02-16 | 2022-02-16 | |
| US63/310,751 | 2022-02-16 | ||
| PCT/US2023/062731 WO2023159120A1 (en) | 2022-02-16 | 2023-02-16 | Certain n-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for treating hidradenitis suppurativa |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508359A JP2025508359A (ja) | 2025-03-26 |
| JP2025508359A5 true JP2025508359A5 (enExample) | 2026-02-19 |
Family
ID=87579133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024546431A Pending JP2025508359A (ja) | 2022-02-16 | 2023-02-16 | 化膿性汗腺炎を治療するためのある特定のｎ－（１－シアノ－２－フェニルエチル）－１，４－オキサゼパン－２－カルボキサミド |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250144116A1 (enExample) |
| EP (1) | EP4479059A4 (enExample) |
| JP (1) | JP2025508359A (enExample) |
| KR (1) | KR20240148350A (enExample) |
| CN (1) | CN118695864A (enExample) |
| AU (1) | AU2023221393A1 (enExample) |
| CA (1) | CA3244131A1 (enExample) |
| GB (1) | GB2630719A (enExample) |
| IL (1) | IL314769A (enExample) |
| MX (1) | MX2024009995A (enExample) |
| WO (1) | WO2023159120A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2699580T3 (enExample) | 2014-01-24 | 2018-02-24 | ||
| PT3758708T (pt) | 2018-03-01 | 2025-02-13 | Astrazeneca Ab | Composições farmacêuticas compreendendo (2s)-{(1,s)-1-ciano-2-[4-(3-metil-2-oxo-2,3-di-hidro-1,3-benzoxazol-5-il)fenil]etil}-1,4-oxazepano-2-carboxamida |
| CA3106269A1 (en) | 2018-07-17 | 2020-01-23 | Insmed Incorporated | Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating lupus nephritis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2699580T3 (enExample) * | 2014-01-24 | 2018-02-24 | ||
| WO2018022978A1 (en) * | 2016-07-29 | 2018-02-01 | Insmed Incorporated | Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasis |
| EP3749326A4 (en) * | 2018-02-07 | 2021-11-03 | Insmed Incorporated | CERTAIN (2S) -N - [(1S) -1-CYANO-2-PHENYLETHYL] -1,4-OXAZEPAN-2-CARBOXAMIDE FOR THE TREATMENT OF VASCULITIDES ASSOCIATED WITH ANCA |
| EP4252844A3 (en) * | 2019-04-17 | 2023-12-06 | Azora Therapeutics, Inc. | Topical compositions and methods for treating inflammatory skin diseases |
| WO2024026433A2 (en) * | 2022-07-28 | 2024-02-01 | Insmed Incorporated | Novel dpp1 inhibitors and uses thereof |
-
2023
- 2023-02-16 JP JP2024546431A patent/JP2025508359A/ja active Pending
- 2023-02-16 GB GB2412566.8A patent/GB2630719A/en active Pending
- 2023-02-16 CN CN202380021843.7A patent/CN118695864A/zh active Pending
- 2023-02-16 EP EP23757082.5A patent/EP4479059A4/en not_active Withdrawn
- 2023-02-16 IL IL314769A patent/IL314769A/en unknown
- 2023-02-16 MX MX2024009995A patent/MX2024009995A/es unknown
- 2023-02-16 AU AU2023221393A patent/AU2023221393A1/en active Pending
- 2023-02-16 CA CA3244131A patent/CA3244131A1/en active Pending
- 2023-02-16 WO PCT/US2023/062731 patent/WO2023159120A1/en not_active Ceased
- 2023-02-16 US US18/838,823 patent/US20250144116A1/en active Pending
- 2023-02-16 KR KR1020247027154A patent/KR20240148350A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023002662A5 (enExample) | ||
| JP2021530513A5 (enExample) | ||
| JP2021063088A5 (enExample) | ||
| JP2024540142A5 (enExample) | ||
| JP2024516826A5 (enExample) | ||
| JP2024009951A5 (enExample) | ||
| JP2024540183A5 (enExample) | ||
| JP2022191257A5 (enExample) | ||
| JP2024507810A5 (enExample) | ||
| JP2023525571A5 (enExample) | ||
| JP2015526458A5 (enExample) | ||
| RU2008135979A (ru) | Соединения гидроксиакрилаимда | |
| RU2014132564A (ru) | Хитозан, ковалентно связанный с низкомолекулярным антагонистом интегрина, для нацеленной доставки | |
| JP2021512904A5 (enExample) | ||
| JP2024527023A5 (enExample) | ||
| JP2022552881A5 (enExample) | ||
| JP2024531188A5 (enExample) | ||
| JP2021001221A (ja) | 精神障害の治療における使用のためのイロペリドン代謝物 | |
| JP2022532766A5 (enExample) | ||
| EP4494701A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| JP2024507367A5 (enExample) | ||
| JP2024069223A5 (enExample) | ||
| JP2025508071A5 (enExample) | ||
| JP2023553253A5 (enExample) | ||
| JP2023549849A5 (enExample) |